FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002551695> ?p ?o ?g. }

• W2002551695 abstract "The aim of this pilot study was to examine the effects of additional resistance training after use of Botulinum Toxin-A (BoNT-A) on the upper limbs in children with cerebral palsy (CP). Ten children with CP (9–17 years) with unilaterally affected upper limbs according to Manual Ability Classification System II were assigned to two intervention groups. One group received BoNT-A treatment (group B), the other BoNT-A plus eight weeks resistance training (group BT). Hand and arm use were evaluated by means of the Melbourne assessment of unilateral upper limb function (Melbourne) and Assisting Hand Assessment (AHA). Measures of muscle strength, muscle tone, and active range of motion were used to assess neuromuscular body function. Measurements were performed before and two and five months after intervention start. Change scores and differences between the groups in such scores were subjected to Mann–Whitney U and Wilcoxon Signed Rank tests, respectively. Both groups had very small improvements in AHA and Melbourne two months after BoNT-A injections, without differences between groups. There were significant, or close to significant, short-term treatment effects in favour of group BT for muscle strength in injected muscles (elbow flexion strength, p = .08) and non-injected muscles (elbow extension and supination strength, both p = .05), without concomitant increases in muscle tone. Active supination range improved in both groups, but more so in group BT (p = .09). There were no differences between the groups five months after intervention start. Resistance training strengthens non-injected muscles temporarily and may reduce short-term strength loss that results from BoNT-A injections without increasing muscle tone. Moreover, additional resistance training may increase active range of motion to a greater extent than BoNT-A alone. None of the improvements in neuromuscular impairments further augmented use of the hand and arm. Larger clinical trials are needed to establish whether resistance training can counteract strength loss caused by BoNT-A, whether the combination of BoNT-A and resistance training is superior to BoNT-A or resistance training alone in improving active range of motion, and whether increased task-related training is a more effective approach to improve hand and arm use in children with CP." @default.
• W2002551695 created "2016-06-24" @default.
• W2002551695 creator A5016975897 @default.
• W2002551695 creator A5036697899 @default.
• W2002551695 creator A5044407860 @default.
• W2002551695 creator A5066294991 @default.
• W2002551695 creator A5086385765 @default.
• W2002551695 creator A5089897796 @default.
• W2002551695 date "2012-07-02" @default.
• W2002551695 modified "2023-10-09" @default.
• W2002551695 title "Effectiveness of resistance training in combination with botulinum toxin-A on hand and arm use in children with cerebral palsy: a pre-post intervention study" @default.
• W2002551695 cites W1655189571 @default.
• W2002551695 cites W1964681554 @default.
• W2002551695 cites W1968867688 @default.
• W2002551695 cites W1994134561 @default.
• W2002551695 cites W1999252127 @default.
• W2002551695 cites W2001336881 @default.
• W2002551695 cites W2005607749 @default.
• W2002551695 cites W2007977734 @default.
• W2002551695 cites W2010439133 @default.
• W2002551695 cites W2015033575 @default.
• W2002551695 cites W2033266344 @default.
• W2002551695 cites W2049112041 @default.
• W2002551695 cites W2055804579 @default.
• W2002551695 cites W2056556983 @default.
• W2002551695 cites W2057337590 @default.
• W2002551695 cites W2063636052 @default.
• W2002551695 cites W2065122687 @default.
• W2002551695 cites W2071560083 @default.
• W2002551695 cites W2078691620 @default.
• W2002551695 cites W2098574214 @default.
• W2002551695 cites W2106212323 @default.
• W2002551695 cites W2114841234 @default.
• W2002551695 cites W2115161372 @default.
• W2002551695 cites W2120033324 @default.
• W2002551695 cites W2123018492 @default.
• W2002551695 cites W2137040793 @default.
• W2002551695 cites W2137090716 @default.
• W2002551695 cites W2141393356 @default.
• W2002551695 cites W2144955940 @default.
• W2002551695 cites W2150384337 @default.
• W2002551695 cites W2153132838 @default.
• W2002551695 cites W2153914530 @default.
• W2002551695 cites W2158476470 @default.
• W2002551695 cites W2163677721 @default.
• W2002551695 cites W2169105013 @default.
• W2002551695 cites W2170220038 @default.
• W2002551695 cites W4211262191 @default.
• W2002551695 doi "https://doi.org/10.1186/1471-2431-12-91" @default.
• W2002551695 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3511174" @default.
• W2002551695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22747635" @default.
• W2002551695 hasPublicationYear "2012" @default.
• W2002551695 type Work @default.
• W2002551695 sameAs 2002551695 @default.
• W2002551695 citedByCount "29" @default.
• W2002551695 countsByYear W20025516952014 @default.
• W2002551695 countsByYear W20025516952015 @default.
• W2002551695 countsByYear W20025516952016 @default.
• W2002551695 countsByYear W20025516952017 @default.
• W2002551695 countsByYear W20025516952019 @default.
• W2002551695 countsByYear W20025516952020 @default.
• W2002551695 countsByYear W20025516952021 @default.
• W2002551695 countsByYear W20025516952022 @default.
• W2002551695 crossrefType "journal-article" @default.
• W2002551695 hasAuthorship W2002551695A5016975897 @default.
• W2002551695 hasAuthorship W2002551695A5036697899 @default.
• W2002551695 hasAuthorship W2002551695A5044407860 @default.
• W2002551695 hasAuthorship W2002551695A5066294991 @default.
• W2002551695 hasAuthorship W2002551695A5086385765 @default.
• W2002551695 hasAuthorship W2002551695A5089897796 @default.
• W2002551695 hasBestOaLocation W20025516951 @default.
• W2002551695 hasConcept C141071460 @default.
• W2002551695 hasConcept C1862650 @default.
• W2002551695 hasConcept C2776660947 @default.
• W2002551695 hasConcept C2777478456 @default.
• W2002551695 hasConcept C2778818304 @default.
• W2002551695 hasConcept C2779421357 @default.
• W2002551695 hasConcept C2781184374 @default.
• W2002551695 hasConcept C2781375409 @default.
• W2002551695 hasConcept C42219234 @default.
• W2002551695 hasConcept C60465272 @default.
• W2002551695 hasConcept C71924100 @default.
• W2002551695 hasConcept C99508421 @default.
• W2002551695 hasConceptScore W2002551695C141071460 @default.
• W2002551695 hasConceptScore W2002551695C1862650 @default.
• W2002551695 hasConceptScore W2002551695C2776660947 @default.
• W2002551695 hasConceptScore W2002551695C2777478456 @default.
• W2002551695 hasConceptScore W2002551695C2778818304 @default.
• W2002551695 hasConceptScore W2002551695C2779421357 @default.
• W2002551695 hasConceptScore W2002551695C2781184374 @default.
• W2002551695 hasConceptScore W2002551695C2781375409 @default.
• W2002551695 hasConceptScore W2002551695C42219234 @default.
• W2002551695 hasConceptScore W2002551695C60465272 @default.
• W2002551695 hasConceptScore W2002551695C71924100 @default.
• W2002551695 hasConceptScore W2002551695C99508421 @default.
• W2002551695 hasIssue "1" @default.
• W2002551695 hasLocation W20025516951 @default.
• W2002551695 hasLocation W20025516952 @default.
• W2002551695 hasLocation W20025516953 @default.
• W2002551695 hasLocation W20025516954 @default.

• next